Seamus Mulligan's Net Worth

$837 Million

Estimate Recalculated Feb 27, 2024 08:34PM EST

Who is Seamus Mulligan?

Seamus Mulligan has an estimated net worth of $837 Million. This is based on reported shares across multiple companies, which include Jazz Pharmaceuticals plc, and Emergent BioSolutions Inc..

SEC CIK

Seamus Mulligan's CIK is 0001536639

Past Insider Trading and Trends

2020 was Seamus Mulligan's most active year for acquiring shares with 7 total transactions. Seamus Mulligan's most active month to acquire stocks was the month of July. 2014 was Seamus Mulligan's most active year for disposing of shares, totalling 38 transactions. Seamus Mulligan's most active month to dispose stocks was the month of February. 2018 saw Seamus Mulligan paying a total of $7,228,001.04 for 55,230 shares, this is the most they've acquired in one year. In 2012 Seamus Mulligan cashed out on 2,864,954 shares for a total of $99,120,000.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Jazz Pharmaceuticals plc (JAZZ) Snapshot price: $123.21

See Remarks

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+0.26%
3.08K
1.17M
Aug 11
Form 4
+0.39%
4.5K
$81.76
$367,920.00
1.17M
Jun 8
Form 4
+0.39%
4.5K
$59.13
$266,085.00
1.16M
Mar 4
Form 4
+0.22%
2.56K
1.16M
Aug 5
Form 4
+0.19%
2.25K
1.16M
Jul 29
Form 4
+0.23%
2.71K
1.16M
Aug 6
Form 4
+4.53%
50K
$111.08
$5,553,804.93
1.15M
May 26 - May 27
Form 4
+0.17%
1.92K
1.1M
Aug 8
Form 4
+4.76%
50K
$144.56
$7,228,001.03
1.1M
Nov 15
Form 4
+0.14%
1.5K
1.05M
Aug 9
Form 4
+0.13%
1.36K
1.05M
Aug 10
Form 4
-2.60%
-27.97K
$128.32
-$3,588,787.11
1.05M
Scheduled
Aug 25
Form 4
+0.13%
1.36K
1.08M
Aug 11
Form 4
-2.54%
-27.97K
$150.29
-$4,203,338.90
1.07M
Scheduled
May 24
Form 4
-2.47%
-27.97K
$122.71
-$3,431,904.17
1.1M
Scheduled
Feb 23
Form 4
-2.41%
-27.97K
$145.86
-$4,079,295.97
1.13M
Scheduled
Nov 20 - Nov 23
Form 4
+0.11%
1.31K
1.16M
Aug 7
Form 4
-4.14%
-50.00K
$174.59
-$8,729,522.46
1.16M
Scheduled
Mar 25
Form 4
-3.98%
-50.00K
$185.00
-$9,250,000.00
1.21M
Scheduled
Mar 18
Form 4
-3.82%
-50.00K
$163.40
-$8,169,891.64
1.26M
Scheduled
Dec 23 - Dec 26
Form 4
-3.68%
-50.00K
$163.16
-$8,157,755.53
1.31M
Scheduled
Sep 24 - Sep 25
Form 4
-3.55%
-50.00K
$175.00
-$8,750,000.00
1.36M
Scheduled
Sep 11
Form 4
+0.12%
1.65K
1.41M
Aug 7
Form 4
-3.44%
-50.00K
$149.69
-$7,484,734.70
1.41M
Scheduled
Jun 24 - Jun 25
Form 4
-27.42%
-550.00K
$156.25
-$85,937,500.00
1.46M
Mar 4
Form 4
+0.11%
2.25K
2.01M
Aug 8
Form 4/A
-17.43%
-422.75K
$58.28
-$24,769,000.00
2M
Mar 5 - Mar 8
Form 4
-17.43%
-422.75K
$58.28
-$24,769,000.00
2M
Mar 5 - Mar 8
Form 4
+0.72%
17.5K
2.44M
Aug 9
Form 4
-37.80%
-2.00M
$49.56
-$99,120,000.00
3.29M
Mar 9
Form 3
0
0
No matching records found

Emergent BioSolutions Inc. (EBS) Snapshot price: $1.495

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+15.58%
7.57K
56.14K
Mar 19
Form 3
0
0
No matching records found